Positive late stage rheumatoid arthritis trial results for Abbvie - PharmaTimes
Positive late stage rheumatoid arthritis trial results for Abbvie PharmaTimes
Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.
Comments
Post a Comment